L&K Biomed was granted FDA 510(k) clearance to market the BluEX-C expandable cervical cage.
The device offers various height options, adjustable from 4mm up to a maximum of 15mm upon expansion. It is designed to allow more precise choices tailored to the patient’s anatomical structure and the surgical environment.
An L&K Biomed representative stated, “Height-expandable cervical cages are products that must deliver both a precise expansion mechanism and stability within a small structure, so the number of commercialized products is limited. This FDA [clearance] is more than just an addition to our product lineup; it is proof of our unrivaled technological capability and development competency.”
They added, “We expect that, based on these rare and innovative products, we can further strengthen our penetration in the U.S. market alongside our existing product lineup. We plan to translate this into tangible sales results by ramping up local marketing and sales activities.”
L&K Biomed also plans to apply for FDA clearance for its Stand-alone Cervical Expandable Cage within 2026, completing a full lineup of cervical products.
L&K Biomed was granted FDA 510(k) clearance to market the BluEX-C expandable cervical cage.
The device offers various height options, adjustable from 4mm up to a maximum of 15mm upon expansion. It is designed to allow more precise choices tailored to the patient’s anatomical structure and the surgical environment.
An L&K Biomed...
L&K Biomed was granted FDA 510(k) clearance to market the BluEX-C expandable cervical cage.
The device offers various height options, adjustable from 4mm up to a maximum of 15mm upon expansion. It is designed to allow more precise choices tailored to the patient’s anatomical structure and the surgical environment.
An L&K Biomed representative stated, “Height-expandable cervical cages are products that must deliver both a precise expansion mechanism and stability within a small structure, so the number of commercialized products is limited. This FDA [clearance] is more than just an addition to our product lineup; it is proof of our unrivaled technological capability and development competency.”
They added, “We expect that, based on these rare and innovative products, we can further strengthen our penetration in the U.S. market alongside our existing product lineup. We plan to translate this into tangible sales results by ramping up local marketing and sales activities.”
L&K Biomed also plans to apply for FDA clearance for its Stand-alone Cervical Expandable Cage within 2026, completing a full lineup of cervical products.
Copy to clipboard 
